Anne Borgman
Directeur Technique/Scientifique/R&D chez SUTRO BIOPHARMA, INC.
Fortune : 83 359 $ au 30/04/2024
Profil
Anne E Borgman is currently an Independent Director at NextCure, Inc., a Director at NiKang Therapeutics, Inc., an Independent Director at Curis, Inc., and the Chief Medical Officer at Sutro Biopharma, Inc. She previously worked at Abbott Laboratories as the Head-Global Project, Exelixis, Inc. as the Vice President-Clinical Research & Development, Humanigen, Inc. and Talon Therapeutics, Inc. as the Chief Medical Officer & Vice President, The University of Chicago as a Clinical Associate-Pediatrics, Jazz Pharmaceuticals Plc as the Vice President & Head-Global Therapeutic Area, and Kalobios Pharmaceuticals, Inc. as the Associate Chief Medical Officer.
Dr. Borgman received her undergraduate degree from the University of Illinois and her doctorate from the Stritch School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SUTRO BIOPHARMA, INC.
0,03% | 31/03/2024 | 24 374 ( 0,03% ) | 83 359 $ | 30/04/2024 |
CURIS, INC.
-.--% | 21/05/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Postes actifs de Anne Borgman
| Sociétés | Poste | Début |
|---|---|---|
| NEXTCURE, INC. | Directeur/Membre du Conseil | 01/10/2021 |
| CURIS, INC. | Directeur/Membre du Conseil | 01/10/2022 |
| SUTRO BIOPHARMA, INC. | Directeur Technique/Scientifique/R&D | 28/02/2023 |
NiKang Therapeutics, Inc.
 NiKang Therapeutics, Inc. BiotechnologyHealth Technology NiKang Therapeutics, Inc. operates as biotechnology company. It focuses on developing novel small molecule oncology drug discovery. The company was founded by Zhenhai Gao and is headquartered in Wilmington, DE. | Directeur/Membre du Conseil | 18/01/2023 |
Anciens postes connus de Anne Borgman
| Sociétés | Poste | Fin |
|---|---|---|
| JAZZ PHARMACEUTICALS PLC | Corporate Officer/Principal | 01/03/2022 |
| EXELIXIS, INC. | Corporate Officer/Principal | 01/07/2019 |
| The University of Chicago | Corporate Officer/Principal | 01/01/2010 |
| ABBOTT LABORATORIES | Corporate Officer/Principal | 01/11/2007 |
| Kalobios Pharmaceuticals, Inc. | Corporate Officer/Principal | - |
Formation de Anne Borgman
| University of Illinois | Undergraduate Degree |
| Stritch School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 7 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| HUMANIGEN, INC. | Health Technology |
| JAZZ PHARMACEUTICALS PLC | Health Technology |
| NEXTCURE, INC. | Health Technology |
| CURIS, INC. | Health Technology |
| SUTRO BIOPHARMA, INC. | Health Technology |
| EXELIXIS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Talon Therapeutics, Inc.
 Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Health Technology |
NiKang Therapeutics, Inc.
NiKang Therapeutics, Inc. BiotechnologyHealth Technology NiKang Therapeutics, Inc. operates as biotechnology company. It focuses on developing novel small molecule oncology drug discovery. The company was founded by Zhenhai Gao and is headquartered in Wilmington, DE. | Health Technology |
| Kalobios Pharmaceuticals, Inc. |